Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Acquisitions & Divestments (2017 - 2019)

Historic Change in Acquisitions & Divestments for Fortress Biotech (FBIO) over the last 3 years, with Q4 2019 value amounting to $5.0 million.

  • Fortress Biotech's Change in Acquisitions & Divestments fell 5000.0% to $5.0 million in Q4 2019 from the same period last year, while for Dec 2020 it was $5.0 million, marking a year-over-year decrease of 7788.0%. This contributed to the annual value of $22.6 million for FY2019, which is 6816.43% down from last year.
  • According to the latest figures from Q4 2019, Fortress Biotech's Change in Acquisitions & Divestments is $5.0 million, which was down 5000.0% from $5.0 million recorded in Q2 2019.
  • In the past 5 years, Fortress Biotech's Change in Acquisitions & Divestments ranged from a high of $25.0 million in Q3 2018 and a low of $8000.0 during Q2 2017
  • Over the past 3 years, Fortress Biotech's median Change in Acquisitions & Divestments value was $11.0 million (recorded in 2018), while the average stood at $11.4 million.
  • As far as peak fluctuations go, Fortress Biotech's Change in Acquisitions & Divestments soared by 14992500.0% in 2018, and later tumbled by 5797.37% in 2019.
  • Quarter analysis of 3 years shows Fortress Biotech's Change in Acquisitions & Divestments stood at $20.1 million in 2017, then crashed by 50.15% to $10.0 million in 2018, then tumbled by 50.0% to $5.0 million in 2019.
  • Its Change in Acquisitions & Divestments stands at $5.0 million for Q4 2019, versus $5.0 million for Q2 2019 and $12.6 million for Q1 2019.